Lucira Health (LHDX)

Lucira Health Stock Analysis & Ratings

LHDX Stock Chart & Stats

Day’s Range$2 - $2.29
52-Week Range$1.98 - $11.10
Previous Close$2.18
Average Volume (3M)122.06K
Market Cap$82.53M
P/E Ratio-1.3
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score3
EPS (TTM)-1.67



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Lucira Health’s price range in the past 12 months?
Lucira Health lowest stock price was $1.98 and its highest was $11.10 in the past 12 months.
    What is Lucira Health’s market cap?
    Lucira Health’s market cap is $82.53M.
      What is Lucira Health’s price target?
      The average price target for Lucira Health is $4.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $4.00 ,the lowest forecast is $4.00. The average price target represents 93.24% Increase from the current price of $2.07.
        What do analysts say about Lucira Health?
        Lucira Health’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Lucira Health’s upcoming earnings report date?
          Lucira Health’s upcoming earnings report date is Aug 11, 2022 which is in 83 days.
            How were Lucira Health’s earnings last quarter?
            Lucira Health released its earnings results on May 12, 2022. The company reported $0.398 earnings per share for the quarter, beating the consensus estimate of -$0.023 by $0.421.
              Is Lucira Health overvalued?
              According to Wall Street analysts Lucira Health’s price is currently Undervalued.
                Does Lucira Health pay dividends?
                Lucira Health does not currently pay dividends.
                What is Lucira Health’s EPS estimate?
                Lucira Health’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Lucira Health have?
                Lucira Health has 39,870,000 shares outstanding.
                  What happened to Lucira Health’s price movement after its last earnings report?
                  Lucira Health reported an EPS of $0.398 in its last earnings report, beating expectations of -$0.023. Following the earnings report the stock price went up 2.308%.
                    Which hedge fund is a major shareholder of Lucira Health?
                    Currently, no hedge funds are holding shares in LHDX


                    Lucira Health Stock Analysis

                    Smart Score
                    Price Target
                    ▲(93.24% Upside)
                    Moderate Buy
                    The Lucira Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Lucira Health

                    Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis